Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2016 054 787.2 |
96 | EP file number | EAKZ | 16 71 8786.3 |
86 | WO file number | WAKZ | PCT/US2016/026437 |
97 | EP publication number | EPN | 3280795 |
87 | WO publication number | WPN | 2016164580 |
54 | Designation/title | TI | KOMBINATION VON CHIMÄRER ANTIGEN REZEPTOR THERAPIE UND AMINO PYRIMIDIN DERIVATEN |
51 | IPC main class | ICM (ICMV) | A61K 31/505 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/506 (2006.01), A61K 45/06 (2006.01), A61P 35/00 (2006.01), A61P 35/02 (2006.01) |
22 | DE application date | DAT | Apr 7, 2016 |
96 | EP application date | EAT | Apr 7, 2016 |
86 | WO application date | WAT | Apr 7, 2016 |
43 | Date of first publication | OT | Oct 13, 2016 |
| Date of publication of grant | PET | Mar 24, 2021 |
71/73 | Applicant/owner | INH | Novartis AG, Basel, CH; The Trustees Of The University Of Pennsylvania, Philadelphia, PA, US |
72 | Inventor | IN | BYRD, John, Columbus, OH 43212, US; DUBOVSKY, Jason, Columbus, OH 43235, US; JOHNSON, Amy, Dublin, OH 43016, US; JUNE, Carl, H., Merion Station, PA 19066, US; MUTHUSAMY, Natarajan, Galloway, OH, US; PORTER, David, L., Springfield, PA 19064, US; WASIK, Mariusz, Ardmore, PA 19003, US; ANGST, Daniela, 4002 Basel, CH; FRAIETTA, Joseph, A., Williamstown, NJ 08094, US; GESSIER, Francois, 4002 Basel, CH; GILL, Saar, Philadelphia, PA 19106, US; MAUS, Marcela, Lexington, MA 02421, US; RUELLA, Marco, Philadelphia, PA 19143, US; Vulpetti, Anna, 4002 Basel, CH |
74 | Representative | VTR | Mathys & Squire Europe Patentanwälte Partnerschaft mbB, 80333 München, DE |
| Address for service | | Mathys & Squire Europe Patentanwälte Partnerschaft mbB, 80333 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201562144188 P Apr 7, 2015
|
| Due date | FT FG | Apr 30, 2026 Annual fee for the 11th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003280795A1 Searchable text:
EP000003280795A1 Original document:
EP000003280795B1 Searchable text:
EP000003280795B1 Original document:
WO002016164580 Searchable text:
WO002016164580 |
43 | Date of first publication | EVT | Oct 13, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Feb 14, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 18, 2025 (Show all update days)(Hide all update days)- Apr 18, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 24.03.2021: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 24.03.2021: deleted
- Mar 15, 2025
- Sep 19, 2024
- St.36: changed (technical change)
- Jun 11, 2024; May 8, 2024; Mar 26, 2024; Apr 8, 2023; Mar 26, 2022; Mar 10, 2022; Feb 17, 2022; Sep 1, 2021; Jun 1, 2021; May 29, 2021; May 1, 2021; Apr 15, 2021; Mar 5, 2021; Mar 4, 2021; Sep 24, 2020; Mar 19, 2020; Aug 22, 2019; Apr 18, 2019; Jun 28, 2018
- Historical data not available for this/these date(s)
- Feb 14, 2018
- Date of the first transfer into DPMAregister
|